Koninklijke Philips Research and Development Expenses 2010-2023 | PHG
Koninklijke Philips annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Koninklijke Philips research and development expenses for the quarter ending September 30, 2023 were $0.484B, a 14.47% decline year-over-year.
- Koninklijke Philips research and development expenses for the twelve months ending September 30, 2023 were $2.083B, a 0.52% increase year-over-year.
- Koninklijke Philips annual research and development expenses for 2023 were $2.046B, a 7.68% decline from 2022.
- Koninklijke Philips annual research and development expenses for 2022 were $2.216B, a 3.7% increase from 2021.
- Koninklijke Philips annual research and development expenses for 2021 were $2.137B, a 2.32% decline from 2020.
| Koninklijke Philips Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $2,046 |
| 2022 | $2,216 |
| 2021 | $2,137 |
| 2020 | $2,188 |
| 2019 | $2,110 |
| 2018 | $2,077 |
| 2017 | $1,994 |
| 2016 | $2,236 |
| 2015 | $2,140 |
| 2014 | $2,173 |
| 2013 | $2,302 |
| 2012 | $2,328 |
| 2011 | $2,242 |
| 2010 | $2,093 |
| 2009 | $2,275 |
| Koninklijke Philips Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-09-30 | $484 |
| 2023-06-30 | $510 |
| 2023-03-31 | $567 |
| 2022-06-30 | $521 |
| 2021-06-30 | $566 |
| 2020-06-30 | $501 |
| 2019-06-30 | $498 |
| 2018-06-30 | $507 |
| 2017-06-30 | $463 |
| 2016-12-31 | $579 |
| 2016-09-30 | $573 |
| 2016-06-30 | $566 |
| 2016-03-31 | $519 |
| 2015-12-31 | $589 |
| 2015-09-30 | $524 |
| 2015-06-30 | $534 |
| 2015-03-31 | $492 |
| 2014-12-31 | $485 |
| 2014-09-30 | $528 |
| 2014-06-30 | $584 |
| 2014-03-31 | $576 |
| 2013-12-31 | $620 |
| 2013-09-30 | $579 |
| 2013-06-30 | $543 |
| 2013-03-31 | $560 |
| 2012-12-31 | $634 |
| 2012-09-30 | $552 |
| 2012-06-30 | $562 |
| 2012-03-31 | $581 |
| 2011-12-31 | $609 |
| 2011-09-30 | $551 |
| 2011-06-30 | $548 |
| 2011-03-31 | $535 |
| 2010-12-31 | $560 |
| 2010-09-30 | $506 |
| 2010-06-30 | $508 |
| 2010-03-31 | $520 |
| 2009-12-31 | $643 |
| 2009-09-30 | $532 |
| 2009-06-30 | $571 |
| 2009-03-31 | $530 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.962B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.209B | 23.86 |
| Stryker (SYK) | United States | $125.934B | 30.16 |
| Medtronic (MDT) | Ireland | $109.997B | 15.57 |
| Boston Scientific (BSX) | United States | $108.110B | 34.43 |
| EssilorLuxottica (ESLOY) | France | $100.536B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.244B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.625B | 27.47 |
| ResMed (RMD) | United States | $31.412B | 29.49 |
| Terumo (TRUMY) | Japan | $25.118B | 35.47 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.957B | 15.94 |
| Baxter (BAX) | United States | $18.187B | 12.93 |
| Insulet (PODD) | United States | $11.617B | 51.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.025B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.042B | 26.31 |
| BellRing Brands (BRBR) | United States | $7.836B | 36.71 |
| Lantheus Holdings (LNTH) | United States | $5.269B | 13.13 |
| Haemonetics (HAE) | United States | $4.868B | 24.09 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.186B | 12.69 |
| Prestige Consumer Healthcare (PBH) | United States | $3.495B | 16.52 |
| Envista Holdings (NVST) | United States | $3.186B | 13.15 |
| QuidelOrtho (QDEL) | United States | $2.850B | 15.84 |
| Green Thumb Industries (GTBIF) | United States | $2.719B | 53.86 |
| Neogen (NEOG) | United States | $2.671B | 25.69 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.630B | 0.00 |
| ICU Medical (ICUI) | United States | $2.610B | 23.03 |
| TG Therapeutics (TGTX) | United States | $2.569B | 72.26 |
| Agios Pharmaceuticals (AGIO) | United States | $1.874B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.717B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.709B | 50.09 |
| InMode (INMD) | Israel | $1.520B | 8.08 |
| Warby Parker (WRBY) | United States | $1.466B | 0.00 |
| Owens & Minor (OMI) | United States | $1.425B | 12.42 |
| AdaptHealth (AHCO) | United States | $1.285B | 9.57 |
| National Vision Holdings (EYE) | United States | $1.160B | 36.90 |
| AtriCure (ATRC) | United States | $1.061B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.917B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.885B | 0.00 |
| Evolus (EOLS) | United States | $0.798B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.711B | 15.13 |
| Quanterix (QTRX) | United States | $0.638B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.628B | 14.77 |
| PetIQ (PETQ) | United States | $0.543B | 17.73 |
| Jin Medical (ZJYL) | China | $0.536B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.459B | 28.71 |
| Biote (BTMD) | United States | $0.456B | 8.74 |
| ZimVie (ZIMV) | United States | $0.454B | 38.72 |
| OraSure Technologies (OSUR) | United States | $0.372B | 11.57 |
| Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
| Zynex (ZYXI) | United States | $0.333B | 45.61 |
| Cerus (CERS) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 27.48 |
| Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.247B | 15.28 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| Omeros (OMER) | United States | $0.203B | 0.00 |
| Veru (VERU) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.182B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
| InterCure (INCR) | Israel | $0.145B | 24.54 |
| Eagleford Energy (GRUSF) | United States | $0.139B | 70.00 |
| FitLife Brands (FTLF) | United States | $0.138B | 22.22 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.110B | 0.00 |
| Fonar (FONR) | United States | $0.107B | 9.17 |
| MariMed (MRMD) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
| Safety Shot (SHOT) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.85 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 14.08 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.027B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 74.77 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |